Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Compliance – Field Commercialization, with support from the Sr. Director, Compliance, is responsible for leading the field-facing compliance strategy and program for Commercial and Medical field organizations during product commercialization and indication expansion. This role serves as a senior compliance business partner to Commercial and Medical business partners, providing strategic guidance that enables compliant execution while advancing organizational objectives. Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company's growth as a commercial-stage oncology organization. This role will proactively identify compliance risks, develop scalable solutions, and influence business decisions across a dynamic and evolving commercial environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior